Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

BackgroundAlthough a recent study reported that fibrates are associated with a low risk of cardiovascular (CV) death and can postpone the need for long-term hemodialysis in patients with advanced chronic kidney disease (CKD), little is known regarding whether the CV protective effects of fibrates ex...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Wen-Yu Ho, Chieh-Li Yen, Cheng-Chia Lee, Yi-Ran Tu, Chao-Yu Chen, Ching-Chung Hsiao, Pao-Hsien Chu, Hsiang-Hao Hsu, Ya-Chun Tian, Chih-Hsiang Chang
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Frontiers Media S.A. 2022-11-01
Sarja:Frontiers in Cardiovascular Medicine
Aiheet:
fibrates
hypertriglyceridemia
end-stage renal disease
cardiovascular
mortality
Linkit:https://www.frontiersin.org/articles/10.3389/fcvm.2022.907539/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.907539/full

Samankaltaisia teoksia